Recombinant Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99
-
Catalog number
7-07868
-
Price
Please ask
-
Size
10µg
-
-
Shelf life
The shelf life of this product is 12 mois
-
Storage
The storage of this product is at: -20℃
-
Shipping
The shipping of this product is in: RT
-
Description
Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.
-
Source
Recombinants or rec. proteins
-
Group
recombinants
-
Gene target
-
Short name
Recombinant Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99
-
Technique
Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. CHI Scientific advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
Species
Virus, Influenza, Viruses
-
Alternative name
Rec. Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99
-
Alternative technique
rec
-
Virus
influenza
-
MeSH Data
-
Name
-
Concept
Scope note:
Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)
-
Tree numbers
- E01.370.225.812.735.050.375
- E05.200.812.735.050.375
- E05.478.594.760.050.375
-
Qualifiers
ethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data
Similar products